59 related articles for article (PubMed ID: 9177701)
1. A radioactive binding assay for inhibitors of trkA kinase.
Knight E; Connors TJ; Maroney AC; Angeles TS; Hudkins RL; Dionne CA
Anal Biochem; 1997 May; 247(2):376-81. PubMed ID: 9177701
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity.
Angeles TS; Steffler C; Bartlett BA; Hudkins RL; Stephens RM; Kaplan DR; Dionne CA
Anal Biochem; 1996 Apr; 236(1):49-55. PubMed ID: 8619495
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
Wiesmann C; Ultsch MH; Bass SH; de Vos AM
Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
[TBL] [Abstract][Full Text] [Related]
4. TrkA as a life and death receptor: receptor dose as a mediator of function.
Yan C; Liang Y; Nylander KD; Schor NF
Cancer Res; 2002 Sep; 62(17):4867-75. PubMed ID: 12208732
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of trkA tyrosine kinase activity and inhibition by K-252a.
Angeles TS; Yang SX; Steffler C; Dionne CA
Arch Biochem Biophys; 1998 Jan; 349(2):267-74. PubMed ID: 9448714
[TBL] [Abstract][Full Text] [Related]
6. Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay.
Sadick MD; Galloway A; Shelton D; Hale V; Weck S; Anicetti V; Wong WL
Exp Cell Res; 1997 Aug; 234(2):354-61. PubMed ID: 9260905
[TBL] [Abstract][Full Text] [Related]
7. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
Greco A; Orlandi R; Mariani C; Miranda C; Borrello MG; Cattaneo A; Pagliardini S; Pierotti MA
Cell Growth Differ; 1993 Jul; 4(7):539-46. PubMed ID: 8398895
[TBL] [Abstract][Full Text] [Related]
8. Regulation of NGF responsiveness in human neuroblastoma.
Bogenmann E; Peterson S; Maekawa K; Matsushima H
Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
[TBL] [Abstract][Full Text] [Related]
9. Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis.
Jiang H; Movsesyan V; Fink DW; Fasler M; Whalin M; Katagiri Y; Monshipouri M; Dickens G; Lelkes PI; Guroff G; Lazarovici P
J Cell Biochem; 1997 Aug; 66(2):229-44. PubMed ID: 9213224
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor.
Holden PH; Asopa V; Robertson AG; Clarke AR; Tyler S; Bennett GS; Brain SD; Wilcock GK; Allen SJ; Smith SK; Dawbarn D
Nat Biotechnol; 1997 Jul; 15(7):668-72. PubMed ID: 9219271
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
Dionne CA; Camoratto AM; Jani JP; Emerson E; Neff N; Vaught JL; Murakata C; Djakiew D; Lamb J; Bova S; George D; Isaacs JT
Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors.
Skoff AM; Adler JE
Exp Neurol; 2006 Feb; 197(2):430-6. PubMed ID: 16300761
[TBL] [Abstract][Full Text] [Related]
13. The role of tropomyosin-related kinase receptors in neurotrophin-induced rapid eye movement sleep in the cat.
Yamuy J; Ramos O; Torterolo P; Sampogna S; Chase MH
Neuroscience; 2005; 135(2):357-69. PubMed ID: 16125858
[TBL] [Abstract][Full Text] [Related]
14. A nerve growth factor-induced retrograde survival signal mediated by mechanisms downstream of TrkA.
Mok SA; Campenot RB
Neuropharmacology; 2007 Feb; 52(2):270-8. PubMed ID: 16949623
[TBL] [Abstract][Full Text] [Related]
15. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons.
Riccio A; Pierchala BA; Ciarallo CL; Ginty DD
Science; 1997 Aug; 277(5329):1097-100. PubMed ID: 9262478
[TBL] [Abstract][Full Text] [Related]
16. Small molecule nerve growth factor analogs image receptors in vivo.
LeSauteur L; Cheung NK; Lisbona R; Saragovi HU
Nat Biotechnol; 1996 Sep; 14(9):1120-2. PubMed ID: 9631063
[TBL] [Abstract][Full Text] [Related]
17. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E
J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587
[TBL] [Abstract][Full Text] [Related]
18. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives.
Kaneko M; Saito Y; Saito H; Matsumoto T; Matsuda Y; Vaught JL; Dionne CA; Angeles TS; Glicksman MA; Neff NT; Rotella DP; Kauer JC; Mallamo JP; Hudkins RL; Murakata C
J Med Chem; 1997 Jun; 40(12):1863-9. PubMed ID: 9191963
[TBL] [Abstract][Full Text] [Related]
20. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
